The 20 Best Triple-Negative Breast Cancer Doctors Near Me in Burlington, MA

Elizabeth Mittendorf is a Surgical Oncologist in Boston, Massachusetts. Dr. Mittendorf is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Lymphadenectomy.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer. Dr. Lynce is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer.

Aditya Bardia is an Oncologist in Boston, Massachusetts. Dr. Bardia is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, Agranulocytosis, and Tissue Biopsy.

Saritha Bolla is an Internal Medicine specialist and an Oncologist in Winchester, Massachusetts. Dr. Bolla is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer.

Gerburg Wulf is an Internal Medicine provider in Boston, Massachusetts. Dr. Wulf is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT).

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Etin-osa Osa is a Radiation Oncologist in Burlington, Massachusetts. Dr. Osa has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Howard Hsu is a Radiation Oncologist in Burlington, Massachusetts. Dr. Hsu is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Christopher Wright is a Radiation Oncologist in Burlington, Massachusetts. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Naomi Jiang is a Radiation Oncologist in Burlington, Massachusetts. Dr. Jiang is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Marginal Zone Lymphoma (MZL), Prostate Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma.

Julie O'brien is a General Surgeon in Burlington, Massachusetts. Dr. O'brien is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Intraductal Papilloma, Paget Disease of the Breast, Breast Cancer, Giant Mammary Hamartoma, and Lymphadenectomy.

Asa Nixon is a Radiation Oncologist in Burlington, Massachusetts. Dr. Nixon is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Large-Cell Lung Carcinoma.

Corrine Zarwan is an Oncologist in Burlington, Massachusetts. Dr. Zarwan is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Endometrial Cancer, Paget Disease of the Breast, and Ovarian Cancer.

Lata Thatai is an Oncologist in Burlington, Massachusetts. Dr. Thatai is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, Liver Embolization, and Gastrostomy.

Klaudia Hunter is a Radiation Oncologist in Burlington, Massachusetts. Dr. Hunter is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Intraductal Papilloma, Laryngeal Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Lyubov Girshovich is a Radiation Oncologist in Burlington, Massachusetts. Dr. Girshovich is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Endometrial Cancer.

Nadine Tung is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.